N. Gauthier

Learn More
Oxaliplatin-based regimens induce a potential risk of hypersensitivity reaction (HSR), with incidence varying from 10% to 25% and lack of clearly identified risk factors. The present study aimed to assess incidence and risk factors in HSR. All patients treated with oxaliplatin in the Medical Oncology Department of the Lyon Sud University Hospital (Hospices(More)
  • 1